Evolus, Inc. is an innovative aesthetic medical company headquartered in Newport Beach, California, primarily focused on developing and marketing advanced beauty solutions for healthcare providers and their patients. The company's flagship product, Jeuveau, is a highly effective neuromodulator specifically designed for the cosmetic market, highlighting Evolus’ commitment to delivering high-quality aesthetic enhancements. With a strategic emphasis on expanding its product portfolio and increasing market presence, Evolus is well-positioned to leverage the rising demand in the aesthetic industry, establishing itself as a key player in reshaping beauty standards while meeting the evolving needs of consumers. Show more
Location: 520 NEWPORT CENTER DRIVE, NEWPORT BEACH, CA, UNITED STATES, 92660, Newport Beach, CA, 92660, USA | Website: https://www.evolus.com | Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC | Sector: HEALTHCARE
Market Cap
304M
52 Wk Range
$4.56 - $17.12
Previous Close
$4.66
Open
$4.64
Volume
1,048,977
Day Range
$4.56 - $4.79
Enterprise Value
415.4M
Cash
43.52M
Avg Qtr Burn
-14.67M
Insider Ownership
13.55%
Institutional Own.
83.92%
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
Evolysse™ Details Nasolabial fold lines | Approved Quarterly sales | |
Jeuveau (prabotulinumtoxinA-xvfs) Details Glabellar lines , Benign tumor | Approved Quarterly sales | |
Jeuveau “Extra-Strength” Details Glabellar lines | Phase 2 Update |